https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/diagnosis-treatment/drc-20353383
Learn how multiple myeloma is diagnosed and treated with various therapies, including targeted, immunotherapy, CAR-T, chemotherapy, corticosteroids, bone marrow transplant and radiation. Find out how treatment depends on the stage, risk level and symptoms of the disease.

https://www.cancer.org/cancer/types/multiple-myeloma/treating.html
Learn about the different treatment options for multiple myeloma, a type of blood cancer that affects plasma cells. Find out how to choose the best treatment plan for you, based on your stage, goals, and preferences.

https://my.clevelandclinic.org/health/diseases/6178-multiple-myeloma
Multiple myeloma causes many symptoms, but bone pain often is the first symptom people notice. Other symptoms include: Weakness in your arms and legs and/or a sensation of numbness in your arms and legs. Multiple myeloma can affect the bones in your spine, causing them to collapse and press on your spinal cord.

https://www.cancer.org/cancer/types/multiple-myeloma/treating/by-stage.html
Learn about the different treatments for multiple myeloma and other plasma cell disorders, depending on the stage and risk of the disease. Find out about drug combinations, stem cell transplant, CAR T-cell therapy, and more.

https://www.dana-farber.org/cancer-care/types/multiple-myeloma/treatment
Learn about the personalized and innovative approaches to treat multiple myeloma at the Jerome Lipper Multiple Myeloma Center. Find out about the latest therapies, clinical trials, and resources for patients and families.

https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/symptoms-causes/syc-20353378
Learn about multiple myeloma, a cancer of plasma cells that affects bone marrow and causes complications. Find out about diagnosis, treatment options and risk factors from Mayo Clinic experts.

https://www.cancer.gov/types/myeloma/patient/myeloma-treatment-pdq
Learn about the types, causes, symptoms, diagnosis, and treatment of plasma cell neoplasms, including multiple myeloma. Find out how age, stage, and other factors affect the prognosis and options for these diseases.

https://www.cancer.org/cancer/types/multiple-myeloma.html
Learn about multiple myeloma, a type of blood cancer that affects plasma cells. Find out about risk factors, symptoms, diagnosis, treatment options, and more.

https://www.myeloma.org/frontline-treatment-options
Learn about the standard of care and emerging options for frontline treatment of multiple myeloma, based on your transplant eligibility and risk factors. Find out how to achieve remission, manage side effects, and consult with a myeloma expert.

https://www.mskcc.org/cancer-care/types/multiple-myeloma/multiple-myeloma-treatment
Multiple Myeloma Treatment. The treatments for active multiple myeloma are: Chemotherapy. Immune-modifying drugs or other medications. Stem cell transplants. Your treatment depends on your stage of myeloma and other information. Often, you will have a combination of a few different drugs. MSK offers many treatments and procedures for bone pain.

https://www.mskcc.org/news/multiple-myeloma-improved-prognosis-latest-treatments
Learn about the current outlook and new drug treatments for multiple myeloma, a rare cancer of plasma cells. Find out how MSK experts are developing and testing innovative therapies, such as CAR T cells and bispecific antibodies.

https://www.cancer.gov/types/myeloma
Learn about the causes, treatment, and statistics of plasma cell neoplasms, a type of blood cancer that affects plasma cells. Find out about the latest research and clinical trials for multiple myeloma and other plasma cell disorders.

https://www.mdanderson.org/cancer-types/multiple-myeloma/multiple-myeloma-treatment.html
Learn about the different therapies for multiple myeloma, a type of blood cancer that affects plasma cells. Find out how MD Anderson offers innovative treatments such as immunotherapy, targeted therapy, radiation therapy and stem cell transplants.

https://themmrf.org/diagnosis-and-treatment/treatment-options/
Learn about the treatment options for multiple myeloma, a type of blood cancer, based on the stage and features of your disease. Find out how to choose the best treatment plan for you, including induction, transplant, maintenance, and relapsed/refractory therapies.

https://www.webmd.com/cancer/multiple-myeloma/multiple-myeloma-treatment
Learn about the drugs, procedures, and lifestyle changes that can help you manage multiple myeloma, a type of blood cancer. Find out how to shrink tumors, stop the disease, and prevent complications.

https://www.mskcc.org/cancer-care/types/multiple-myeloma
Multiple myeloma (MUL-tih-pul MY-eh-LOH-muh) is a rare cancer. There only are about 35,000 cases in the United States each year. Multiple myeloma is a disease that cannot be cured. But it can be managed for many years with the right care. Every year, MSK treat hundreds of people diagnosed with multiple myeloma or a related plasma cell disease.

https://www.webmd.com/cancer/multiple-myeloma/multiple-myeloma-symptoms-causes-treatment
Learn about multiple myeloma, a type of blood cancer that affects plasma cells and causes bone problems, infections, and kidney damage. Find out how it's diagnosed and treated with medications, CAR T-cell therapy, or stem cell transplant.

https://www.cancer.gov/types/myeloma/hp/myeloma-treatment-pdq
Evaluation of patients with monoclonal (or myeloma) protein (M protein) Idiotypic myeloma cells can be found in the blood of patients with myeloma in all stages of the disease.[4,5] For this reason, when treatment is indicated, systemic treatment must be considered for all patients with symptomatic plasma cell neoplasms.Patients with MGUS or asymptomatic smoldering myeloma do not require

https://www.ajmc.com/view/revolutionizing-multiple-myeloma-immunotherapy-is-transforming-treatment-extending-lives-dr-mohamad-mohty-says
Mohamad Mohty, MD, PhD, of Saint-Antoine Hospital and Sorbonne University, highlights how immunotherapies are offering various effective treatment options for patients with multiple myeloma and

https://www.uptodate.com/contents/multiple-myeloma-treatment-beyond-the-basics
Learn about the different types of treatment for multiple myeloma, a cancer of plasma cells in the bone marrow. Find out when to start treatment, how medications, transplant, and CAR-T therapy work, and what are the possible side effects.

https://www.uptodate.com/contents/multiple-myeloma-overview-of-management
Multiple myeloma (MM) is a plasma cell neoplasm characterized by clonal plasma cells that produce a monoclonal immunoglobulin. These plasma cells proliferate in the bone marrow and can result in extensive skeletal destruction with osteolytic lesions, osteopenia, and/or pathologic fractures. Additional disease-related complications include

https://www.cancer.org/cancer/types/multiple-myeloma/treating/chemotherapy.html
Learn about the different types of drugs used to treat multiple myeloma, such as chemo, steroids, immunomodulators, and proteasome inhibitors. Find out how they work, what side effects they may cause, and how they are combined.

https://www.nhs.uk/conditions/multiple-myeloma/treatment/
Learn about the different treatments for multiple myeloma, a type of blood cancer that affects the bone marrow. Find out how they work, what side effects they may have, and when they are used.

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00341-3/fulltext
High-dose melphalan followed by autologous haematopoietic stem-cell transplantation (ASCT) has been the standard of care in myeloma treatment for the past three decades, however, the curative success rate is low and quadruplet regimens are gaining acceptance.1 In view of the high response rates observed with daratumumab, anti-CD38 monoclonal antibodies have been added to the backbone of

https://finance.yahoo.com/news/iaso-bio-presented-data-fucaso-143000098.html
Professor Bing Chen from Nanjing Drum Tower Hospital stated: "High-risk newly diagnosed multiple myeloma patients have a poor prognosis in standard first-line treatment. For high-risk NDMM

https://link.springer.com/article/10.1007/s12185-024-03793-1
The introduction of immunotherapies has led to remarkable progress in the treatment of hematological malignancies, including B-cell malignancies such as B-cell lymphoma and multiple myeloma (MM). Although conventional therapeutic antibodies are effective as immunotherapy for newly diagnosed and relapsed/refractory B-cell lymphoma and MM, some cases are resistant. Chimeric antigen receptor (CAR

https://www.cancer.gov/news-events/cancer-currents-blog/2024/multiple-myeloma-darzalex-plus-vrd
A large trial found that adding daratumumab, a targeted cancer drug, to bortezomib, lenalidomide, and dexamethasone improved progression-free survival and minimal residual disease for people with newly diagnosed multiple myeloma. Daratumumab can be given as subcutaneous injections, which cause fewer adverse reactions and are less time-consuming than intravenous infusions.

https://www.morningstar.com/news/pr-newswire/20240615cn39864/iaso-bio-presented-new-data-of-fucaso-equecabtagene-autoleucel-for-the-treatment-of-high-risk-newly-diagnosed-multiple-myeloma-in-oral-presentation-at-eha-2024
Professor Bing Chen from Nanjing Drum Tower Hospital stated: "High-risk newly diagnosed multiple myeloma patients have a poor prognosis in standard first-line treatment. For high-risk NDMM

https://cancerblog.mayoclinic.org/2024/06/13/treatment-and-research-of-glioblastoma/
Mayo Clinic Minute: Treatment and research of glioblastoma. From an accredited US hospital. "It tends to be a tumor that also tends to grow and invade the brain," says Dr. Quinones-Hinojosa. "Sometimes it can be slow and steady, but it tends to grow very fast." Despite significant advances in surgery, chemotherapy, immunotherapy and radiation

https://www.prnewswire.com/news-releases/iaso-bio-presented-new-data-of-fucaso-equecabtagene-autoleucel-for-the-treatment-of-high-risk-newly-diagnosed-multiple-myeloma-in-oral-presentation-at-eha-2024-302173593.html
Professor Bing Chen from Nanjing Drum Tower Hospital stated: "High-risk newly diagnosed multiple myeloma patients have a poor prognosis in standard first-line treatment. For high-risk NDMM